Skip Navigation

Faculty Directory

Richard E. Chaisson, MD

Richard E. Chaisson Print View
  • Professor

Departmental Affiliations

  • School of Medicine (Primary)
  • Epidemiology (Joint)
    • Division: Infectious Disease Epidemiology
  • International Health (Joint)
    • Division: Global Disease Epidemiology and Control

Center & Institute Affiliations

Contact Information

1550 Orleans Street
Room 108
Baltimore, Maryland 21231

410-955-1755
410-955-0740

Center for TB Research
CFAR

View Current Courses

Education

MD

Overview

Richard E. Chaisson, M.D., is Professor of Medicine, Epidemiology and International Health and Director of the Johns Hopkins University Center for Tuberculosis Research and Principal Investigator of the Hopkins Center for AIDS Research (CFAR). The Center for Tuberculosis Research is a multidisciplinary research and training center for the study of TB from bench to bedside.  The CFAR is a multidisciplinary, university-wide program to promote HIV research, support new investigators, and address the Baltimore HIV epidemic.

Dr. Chaisson's research interests focus on tuberculosis and HIV infection, including global epidemiology and control, prevention, clinical trials, and public health interventions. He is currently principal investigator of 11 research grants, and is principal investigator of the Consortium to Respond Effectively to the AIDS/TB Epidemic (CREATE), an international research consortium funded by the Bill and Melinda Gates Foundation to assess the impact of novel strategies for controlling HIV-related TB. He has published over 425 scientific papers and book chapters.

Honors and Awards

World Lung Health Award, American Thoracic Society, 2006

MD Dept Health & Mental Hygiene David Glasser Award, 2008

CDC Charles C. Shepard Award, 2012

USAID Champions of TB Control Award (for CREATE), 2014

Scientific Award, International Union Against Tuberculosis and Lung Disease, 2014

Association of American Professors, 2016

Fellow, American College of Physicians, 2016

Mentee-Mentor Award for Clinical Research, JHUSOM Office of Postdoctoral Affairs, 2017

  • Tuberculosis
  • HIV
  • Infectious Diseases

Selected publications.

  • Sterling TR, Villarino ME, Borisov AS, Shang N, Gordin F, Bliven-Sizemore E, Hackman J, Hamilton CD, Menzies D, Kerrigan A, Weis SE, Weiner M, Wing D, Conde MB, Bozeman L, Horsburgh CR Jr, Chaisson RE; TB Trials Consortium PREVENT TB Study Team. Three months of rifapentine and isoniazid for latent tuberculosis infection.  N Engl J Med. 2011;365:2155-66.
  • Martinson NA, Barnes GL, Moulton LH, Msandiwa R, Hausler H, Ram M, McIntyre JA, Gray GE, Chaisson RE.  New regimens to prevent tuberculosis in adults with HIV infection.  N Engl J Med 2011;365:11-20. PMCID: PMC3407678
  • Dowdy DW, Golub JE, Chaisson RE, Saraceni V. Heterogeneity in tuberculosis transmission and the role of geographic hotspots in propagating epidemics.  Proc Natl Acad Sci U S A. 2012;109:9557-62
  • Durovni B, Saraceni V, Moulton LM, Pacheco AG, Cavalcante SC, King BS, Cohn S, Efron A, Chaisson RE, Golub JE.  Effect of improved tuberculosis screening and isoniazid preventive therapy on incidence of tuberculosis and death in patients with HIV in clinics in Rio de Janeiro, Brazil: a stepped wedge, cluster-randomised trial. Lancet Infect Dis. 2013;10:852-8
  • Rangaka MX, Cavalcante SC, Martinson N, Marais BJ, Thim S, Swaminathan S, Chaisson RE. Controlling the seedbeds of tuberculosis: diagnosis and treatment of tuberculosis infection. Lancet, 2015;386:2244-53.

See all publications by Richard E. Chaisson

  • Statins as Adjunctive Therapy for Tuberculosis (StAT-TB)

Update your faculty page